Treatment for short bowel syndrome varies by stage and may include intravenous (IV) nutrition, feeding tubes, dietary changes ...
The oral Janus kinase inhibitor upadacitinib was well tolerated for moderate to severe inflammatory bowel disease over a ...
Seven abstracts accepted for presentation include data from long-term follow-up studies and a post-hoc analysis of the ...
Prefilled syringes (PFS) preferred on pharmacy benefit; vials preferred on medical benefit RALEIGH, N.C., April 20, 2026 /PRNewswire/ -- Accord BioPharma, the U.S. specialty division of Intas ...
Biologic therapy within a year of diagnosis could decrease risk for disease progression among patients with ulcerative ...
Older adults with acute severe ulcerative colitis have higher mortality, underscoring the need for targeted strategies to ...
In children hospitalised with acute severe ulcerative colitis on intravenous corticosteroids, intestinal ultrasound (IUS) parameters such as colonic wall thickness (CWT) were associated with ...
Researchers have used machine learning to identify a new antimicrobial peptide that reduces inflammation, restores gut barrier function and reshapes the microbiome in ulcerative colitis. Ulcerative ...
Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by recurrent intestinal inflammation, abdominal pain and diarrhea. Although current treatments, including 5-aminosalicylic ...
Ulcerative colitis (UC) is a chronic, immune-mediated inflammatory disorder of the colon that follows a relapsing-remitting course. Characterised by mucosal inflammation, the disease requires accurate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results